Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Evaluation of Frailty and Functional Capacity in End-Stage Liver Disease

Authors not listed

Hacettepe University · 2022

Abstract

Development of fibrosis plays a main role in the pathophysiology of liver diseases. The rate of progression in fibrogenesis varies according to the type of underlying liver disease and varies with the environment and host-related factors. End-stage liver diseases are characterized by systemic vascular resistance and decreased arterial blood pressure, increased heart rate and cardiac output . Disruption of regulation of neurogenic, humoral and vascular functions is effective in these cardiovascular changes. In end-stage liver diseases, glycogen storage and corruption of glyconeogenesis cause muscle protein and fat to be used for energy, resulting in weight loss and muscle weakness. According to the latest data of the Republic of Turkey Ministry of Health in Turkey in 2223 patients are waiting for liver transplantation. Acute and chronic liver disease and infectious complications lead to an increase in the number of hospitalizations and prolonged hospital stay and severely affect the functional status and mortality. In recent years, more attention has been paid to complications from chronic diseases, including malnutrition, sarcopenia, poor functional capacity, and frailty. There are few studies in the literature examining functional capacity and physical frailty in end-stage liver disease. The aim of this study was to investigate the relationship between functional capacity and frailty in end-stage liver disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-28 MST

Cite this

APA
Anonymous. (2022). Evaluation of Frailty and Functional Capacity in End-Stage Liver Disease. <em>Hacettepe University</em>. https://clinicaltrials.gov/study/NCT04220723
Vancouver
Anonymous. Evaluation of Frailty and Functional Capacity in End-Stage Liver Disease. Hacettepe University. 2022.
BibTeX
@misc{anon2022Evalua, title = {Evaluation of Frailty and Functional Capacity in End-Stage Liver Disease}, author = {Anonymous}, journal = {Hacettepe University}, year = {2022}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings